Mar 30, 2017 12:00 pm UTC| Business
RESEARCH TRIANGLE PARK, N.C., March 30, 2017 -- JAGGAER, producers of the world's most comprehensive Source to Pay (S2P) solutions suite, today announced the release of the 2017 Innovators Forum Report, published in...
CytomX Therapeutics Appoints Marion McCourt to Board of Directors
Mar 30, 2017 12:00 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., March 30, 2017 -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), a biopharmaceutical company developing investigational Probody™ therapeutics for the treatment of cancer, today announced the...
Cardtronics Announces $300 Million Private Offering of Senior Notes
Mar 30, 2017 11:46 am UTC| Business
HOUSTON, March 30, 2017 -- Cardtronics plc (Nasdaq:CATM) (“Cardtronics”), today announced that, subject to market conditions, two of its indirect, wholly-owned subsidiaries, Cardtronics, Inc. and Cardtronics USA, Inc.,...
Fall River Charter School Enters First of its Kind Partnership with MIT BLOSSOMS
Mar 30, 2017 11:45 am UTC| Business
CAMBRIDGE, Mass., March 30, 2017 -- The Massachusetts Institute of Technology (MIT) BLOSSOMS Program (Blended Learning Open Source Science Or Math Studies) today announced it has signed a first-of-its-kind partnership...
Affimed Reports Financial Results for Fourth Quarter and Year End 2016
Mar 30, 2017 11:31 am UTC| Business
Heidelberg, Germany, March 30, 2017 - Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies, today reported financial results...
Amerigo Announces Filing of NI 43-101 Technical Report
Mar 30, 2017 11:30 am UTC| Business
VANCOUVER, British Columbia, March 30, 2017 -- Amerigo Resources Ltd. (TSX:ARG) ("Amerigo" or the "Company") is pleased to announce that it has filed a technical report (the "Report") prepared for Minera Valle Central,...
Agios to Present at the 16th Annual Needham Healthcare Conference on Tuesday April 4, 2017
Mar 30, 2017 11:30 am UTC| Business
CAMBRIDGE, Mass., March 30, 2017 -- Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a leader in the field of cellular metabolism to treat cancer and rare genetic diseases, today announced the company is scheduled to present...